Leng Han

70PUBLICATIONS
169CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Jun 05, 2026
Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.

|May 05, 2026
A retrospective pharmacovigilance analysis based on the FAERS database reveals sex-associated differences in toxicities of CAR T-cell therapy.

|Apr 01, 2026
Integrating Multi-Dimensional Data to Advance Global Health Equity in Oncology.

Yuan Liu, Eytan Ruppin, Leng Han

|Nov 21, 2025
Functional, Pharmacogenomic, and Immune Landscapes of Long Non-Coding RNAs in Cancer.

Runhao Wang, Mei Luo, Yuan Liu

|Mar 21, 2025
Multi-omics analysis identifies glioblastoma dependency on H3K9me3 methyltransferase activity.

Qiqi Xie, Yuanning Du, Sugata Ghosh

|Feb 04, 2025
Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer.

Chenyang Zhang, Yan-Yan Chen, Shuyu Chen

Pageof 12

Frequent Collaborators

16 joint publications

Youqiong Ye

12 joint publications

Zhao Zhang

9 joint publications

Han Liang

9 joint publications

Yuan Liu